This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $850 | To Be Confirmed |
250mg | $1350 | To Be Confirmed |
500mg | $2025 | To Be Confirmed |
Cat #: V2170 CAS #: 171099-57-3 Purity ≥ 99%
Description: Oritavancin (formerly known as LY333328; LY-333328; Orbactiv) is a novel semisynthetic glycopeptide antibiotic medication approved for the treatment of serious Gram-positive bacterial infections. It is a lipoglycopeptide analog of vancomycin containing the heptapeptide core common to all glycopeptides. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci. Oritavancin was more active than either metronidazole or vancomycin against strains of Clostridium difficile tested. Oritavancin has potential use as a therapy for exposure to Bacillus anthracis, the Gram-positive bacterium that causes anthrax, having demonstrated efficacy in a mouse model both before and after exposure to the bacterium. Reference: Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review. Core Evid. 2015 Feb 11;10:39-47.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 1793.10 |
---|---|
Molecular Formula | C86H97Cl3N10O26 |
CAS No. | 171099-57-3 |
SMILES Code | C[C@H]1[C@H](O)[C@@](C)(N)C[C@H](O[C@H]2[C@H]3C(N[C@H](C(O)=O)C4=CC(O)=CC(O)=C4C5=C(O)C=CC([C@@H](NC([C@H]6C7=CC(OC8=C(Cl)C=C2C=C8)=C(O[C@H]9[C@H](O[C@H]%10C[C@](C)(NCC%11=CC=C(C%12=CC=C(Cl)C=C%12)C=C%11)[C@@H](O)[C@H](C)O%10)[C@@H](O)[C@H](O)[C@@H](CO)O9)C(OC%13=C(Cl)C=C([C@@H](O)[C@@H](NC([C@H](NC)CC(C)C)=O)C(N[C@@H](CC(N)=O)C(N6)=O)=O)C=C%13)=C7)=O)C(N3)=O)=C5)=O)O1.O=P(O)(O)O.O=P(O)(O)O |
Synonyms | LY333328; Oritavancin; LY-333328; Oritavancin diphosphate; LY 333328; |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 0.5577 mL | 2.7885 mL | 5.5769 mL | 11.1539 mL |
5mM | 0.1115 mL | 0.5577 mL | 1.1154 mL | 2.2308 mL |
10mM | 0.0558 mL | 0.2788 mL | 0.5577 mL | 1.1154 mL |
20mM | 0.0279 mL | 0.1394 mL | 0.2788 mL | 0.5577 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.